SSO Gives Richard Bloch Its Layman's Award

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 5
Volume 4
Issue 5

BOSTON--During its 48th Cancer Symposium, the Society of Surgical Oncology (SSO) presented Richard A. Bloch, founder of H&R Block, with its James Ewing Layman's Award, given annually to a nonphysician. The award honors Mr. Bloch for his contribution to improving the care of cancer patients.

BOSTON--During its 48th Cancer Symposium, the Society of SurgicalOncology (SSO) presented Richard A. Bloch, founder of H&RBlock, with its James Ewing Layman's Award, given annually toa nonphysician. The award honors Mr. Bloch for his contributionto improving the care of cancer patients.

"In 1978 when Dick Bloch was diagnosed with cancer and toldthat he had only 3 months to live, he refused to accept that prognosis,"said SSO president Bernard Gardner, MD. "He fought back.. . and has spent the past 15 years of his life making sure otherswith cancer have a fighting chance."

Mr. Bloch developed the Physician Data Query (PDQ) computer programused by the National Cancer Institute to maintain a database ofstate-of-the-art cancer treatments. With his wife, Annette, hefounded the Cancer Hot Line in Kansas City, Mo, a volunteer organizationof more than 200 cancer patients.

Recent Videos
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.
Related Content